These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23411886)

  • 1. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
    Naik RK; Rentz AM; Foster CS; Lightman S; Belfort R; Lowder C; Whitcup SM; Kowalski JW; Revicki DA
    JAMA Ophthalmol; 2013 Feb; 131(2):219-25. PubMed ID: 23411886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis.
    Lightman S; Belfort R; Naik RK; Lowder C; Foster CS; Rentz AM; Cui H; Whitcup SM; Kowalski JW; Revicki DA
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4864-70. PubMed ID: 23761087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.
    Sheppard J; Joshi A; Betts KA; Hudgens S; Tari S; Chen N; Skup M; Dick AD
    JAMA Ophthalmol; 2017 Jun; 135(6):511-518. PubMed ID: 28426849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.
    Sugar EA; Venugopal V; Thorne JE; Frick KD; Holland GN; Wang RC; Almanzor R; Jabs DA; Holbrook JT;
    Ophthalmology; 2017 Nov; 124(11):1662-1669. PubMed ID: 28624167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    ; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision- and health-related quality of life in patients with Behçet uveitis.
    Onal S; Savar F; Akman M; Kazokoglu H
    Arch Ophthalmol; 2010 Oct; 128(10):1265-71. PubMed ID: 20937995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT; Banks AD; Stinnett SS; Toth CA
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
    Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD
    Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults.
    Squires H; Poku E; Bermejo I; Cooper K; Stevens J; Hamilton J; Wong R; Denniston A; Pearce I; Quhill F
    Health Technol Assess; 2017 Nov; 21(68):1-170. PubMed ID: 29183563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
    Sakai T; Watanabe H; Kuroyanagi K; Akiyama G; Okano K; Kohno H; Tsuneoka H
    Br J Ophthalmol; 2013 Mar; 97(3):338-42. PubMed ID: 23314623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis.
    Sugar EA; Burke AE; Venugopal V; Thorne JE; Holbrook JT;
    Ophthalmology; 2020 Dec; 127(12):1710-1718. PubMed ID: 32717341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
    Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vision-and health-related quality of life in patients with uveitis].
    Zhang J; Yan HG; Chi Y; Guo CY; Yang L
    Zhonghua Yan Ke Za Zhi; 2016 Jun; 52(6):429-36. PubMed ID: 27373571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
    Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.